secwatch.observer — SEC 8-K summary
======================================

Issuer:     Barinthus Biotherapeutics plc. (BRNS)
CIK:        0001828185
Form:       8-K
Filed at:   2026-09-09T14:24:49+00:00
Accession:  0001104659-26-106183
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 1.02, 2.01, 3.01, 3.03, 5.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Barinthus Biotherapeutics acquired by Beacon Topco; ADS delisted from Nasdaq
----------------------------------------------------------------------------

- Scheme of Arrangement effective Sept 9, 2026; Topco acquired all issued Barinthus shares, company now wholly-owned subsidiary.
- Each Company Share/ADS exchanged for 0.111 Topco common shares; fractional entitlements cashed out.
- ADS trading on Nasdaq suspended before open Sept 9, 2026; Form 25 and Form 15 to be filed to delist and suspend reporting.
- Outstanding Company Options and RSUs assumed by Topco and converted into rights over Topco common stock.
- Deposit Agreement with BNY Mellon terminated; shareholders' rights ceased except consideration under Merger Agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828185/000110465926106183/0001104659-26-106183-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828185/000110465926106183/tm2625093d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-106183

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer